Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens

NCT07689006 · clinicaltrials.gov ↗

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: Pomalidomide-containing regimens
DRUG: Non-pomalidomide-containing regimens

Sponsor

Bristol-Myers Squibb